The gonadotropin-releasing hormone is responsible for the release of follicle stimulating hormone and luteinizing hormone from the pituitary gland.
The gonadotropin-releasing hormone (GnRH) is responsible for the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. The proper functioning of the GnRH is very crucial for the optimum functioning of the reproductive system in females. GnRH analogues (GnRH agonists & antagonists) interact with GnRH receptors in a different way in order to modify the release of hormones for a specified purpose. They can be administered through various routes such as intravenous, intramuscular, oral, subcutaneous, and nasal. GnRh agonists are the class of medications that are used in various indications such as fertility treatment, hormone sensitive cancers, endometriosis in women, delaying puberty, and transgender hormone therapy. GnRH antagonists are the medication class that antagonize the action of the GnRH and are used in the treatment of female infertility and cancers. They usually result in the blockage of natural ovulation.
Read Report Overview - https://www.transparencymarketresearch.com/gnrh-agonists-antagonists-market.html
Increase in government initiatives for birth control measures, increased incidences of prostate cancer among the population, rise in awareness about in-vitro fertilization methods, and increased adoption of GnRH agonists & antagonists are the major factors expected to drive the GnRH agonists & antagonists market. However, high cost of treatment and side effects associated with the treatment are likely to restrain the GnRH agonists & antagonists market. The discovery and development of GnRH antagonists for the treatment of prostate cancer, in order to ensure the effective use of hormone therapy in the treatment of cancer, is an upcoming trend in the GnRH agonists & antagonists market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52716
The GnRH agonists & antagonists market can be segmented based on application, distribution channel, and region. In terms of application, the market can be classified into gynecology, oncology, and others. The gynecology segment includes medications used for contraception and fertilization. The gynecology segment held a prominent share of the market in 2017 due to increased use of contraceptive medications because of campaigns organized by governments in order to spread awareness about birth control measures. The segment is expected to maintain its leadership position during the forecast period. . Based on distribution channel, the GnRH agonists & antagonists market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominated the market in 2017 due to the free availability of birth control medications in government hospitals. The segment is expected to continue to dominate the market from 2018 to 2026.
Request for Analysis of COVID-19 Impact on GnRH Agonists & Antagonists Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=52716
In terms of region, the GnRH agonists & antagonists market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017 due to technological advances in IVF treatment, availability of approved products for oncology treatment, and increased use of birth control pills in the U.S.. The market in Asia Pacific is anticipated to expand at a rapid CAGR owing to a rise in awareness regarding advanced fertilization treatments in developed countries.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=52716
Major players operating in the global GnRH agonists & antagonists market include Ferring B.V., Bayer AG, Endo Pharmaceuticals Inc., AbbVie Inc., Contura Ltd., AstraZeneca plc, TerSera Therapeutics LLC, Shire, Informa plc, and Merck KGaA.
Pre Book GnRH Agonists & Antagonists Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=52716<ype=S
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453